Biopsy-proven Histologic Scores
1 clinical trials · Condition
◉ Watch Biopsy-proven Histologic Scores
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation (NCT06744647) | Alexion Pharmaceuticals, Inc. | 2025-03-07 |
Track Biopsy-proven Histologic Scores automatically
Every clearance here is in the API, with alerts when new ones post.